Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma

被引:50
作者
Dai, Furong [1 ]
Zhang, Yi [1 ]
Chen, Yuxiang [2 ]
机构
[1] Cent S Univ, Xiangya Hosp, Dept Obstet & Gynaecol, Changsha 410008, Hunan, Peoples R China
[2] Cent S Univ, Xiangya Hosp, Hepatobiliary & Enter Surg Res Ctr, Changsha 410008, Hunan, Peoples R China
关键词
Ovarian cancer; Overall survival; Progression-free survival; miR-29b; MAPK10; ATG9A; Mcl1; EXPRESSION; MICRORNAS; CHEMORESISTANCE; AUTOPHAGY; IDENTIFICATION; SIGNATURES; LYMPHOMA; LEUKEMIA; CELLS;
D O I
10.1016/j.humpath.2014.02.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Although the molecular mechanisms driving chemoresistance and relapse of ovarian cancer have been widely studied, the key molecules have not been identified. In this study, the expression of miR-29b messenger RNA (mRNA) and its targeted genes, myeloid cell leukemia sequence 1, mitogen-activated protein lcinase 10 (MAPK10), and autophagy-related protein 9A (ATG9A), were investigated in ovarian carcinomas, and their associations with clinicopathological characteristics and survival of patients with ovarian cancer were analyzed. The protein expression of MCL1, MAPK10, and ATG9A was measured using immunohistochemistry. miR-29b mRNA and ATG9A gene mRNA levels were measured by real-time polymerase chain reaction. Results demonstrated that the percentage of MCL1, MAPK10, and ATG9A protein positive cases were significantly higher, whereas miR-29b was significantly lower in ovarian serous, mucinous, and clear cell carcinomas than that in normal tissues. MAPK10 was significantly associated with higher histopathologic grading. The percentage of positive myeloid cell leukemia sequence 1, ATG9A, and MAPK10 protein expression and low miR-29b mRNA expression were significantly higher in cases with clinical stage ET and IV ovarian cancer than in cases with clinical stage 11 ovarian cancer. High ATG9A protein and low miR-29b mRNA expression were significantly associated with relapse. Univariate Kaplan-Meier analysis showed a negative correlation between MAPK10 or ATG9A protein expression and overall as well as progression-free survival, whereas a positive correlation was observed between miR-29b mRNA expression and overall as well as progression-free survival. Multivariate Cox regression analysis showed that elevated MAPK10 or ATG9A protein and lowered miR-29b mRNA expression in ovarian carcinoma was an independent poor prognostic predictor. Our study suggested that miR-29b mRNA, MAPK10 protein expression, and ATG9A protein expression are closely related to chemosensitivity of ovarian carcinoma. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:1285 / 1293
页数:9
相关论文
共 27 条
[1]  
Blenk S, 2007, CANCER INFORM, V3, P399
[2]   Identification of metastasis-related microRNAs in hepatocellular carcinoma [J].
Budhu, Anuradha ;
Jia, Hu-Liang ;
Forgues, Marshonna ;
Liu, Chang-Gong ;
Goldsteir, David ;
Lam, Amy ;
Zanetti, Krista A. ;
Ye, Qing-Hai ;
Qin, Lun-Yju ;
Croce, Carlo M. ;
Tang, Zhao-You ;
Wang, Xin Wei .
HEPATOLOGY, 2008, 47 (03) :897-907
[3]   Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential [J].
Chistiakov, Dimitry A. ;
Chekhonin, Vladimir P. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 684 (1-3) :8-18
[4]   The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer [J].
Dai, Furong ;
Zhang, Yi ;
Zhu, Xin ;
Shan, Nianchun ;
Chen, Yuxiang .
GYNECOLOGIC ONCOLOGY, 2013, 131 (02) :451-459
[5]   MicroRNAs in Human Cancer [J].
Farazi, Thalia A. ;
Hoell, Jessica I. ;
Morozov, Pavel ;
Tuschl, Thomas .
MICRORNA CANCER REGULATION: ADVANCED CONCEPTS, BIOINFORMATICS AND SYSTEMS BIOLOGY TOOLS, 2013, 774 :1-20
[6]  
Fendler Annika, 2013, Critical Reviews in Oncogenesis, V18, P289
[7]   miR-29b Expression Is Associated With Disease-Free Survival in Patients With Ovarian Serous Carcinoma [J].
Flavin, Richard ;
Smyth, Paul ;
Barrett, Ciara ;
Russell, S. ;
Wen, Hannah ;
Wei, Jianjun ;
Laios, Alex ;
O'Toole, Sharon ;
Ring, M. ;
Denning, K. ;
Li, J. ;
Aherne, S. ;
Sammarae, D. ;
Aziz, N. A. ;
Alhadi, A. ;
Finn, Sephen P. ;
Loda, M. ;
Sheppard, B. ;
Sheils, Orla ;
O'Leary, John J. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (04) :641-647
[8]   MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 [J].
Garzon, Ramiro ;
Liu, Shujun ;
Fabbri, Muller ;
Liu, Zhongfa ;
Heaphy, Catherine E. A. ;
Callegari, Elisa ;
Schwind, Sebastian ;
Pang, Jiuxia ;
Yu, Jianhua ;
Muthusamy, Natarajan ;
Havelange, Violaine ;
Volinia, Stefano ;
Blum, William ;
Rush, Laura J. ;
Perrotti, Danilo ;
Andreeff, Michael ;
Bloomfield, Clara D. ;
Byrd, John C. ;
Chan, Kenneth ;
Wu, Lai-Chu ;
Croce, Carlo M. ;
Marcucci, Guido .
BLOOD, 2009, 113 (25) :6411-6418
[9]   Designing Early Detection Programs for Ovarian Cancer [J].
Hartge, Patricia .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (01) :3-3
[10]   Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel [J].
Hassan, Mohamed Kamel ;
Watari, Hidemichi ;
Christenson, Lane ;
Bettuzzi, Saverio ;
Sakuragi, Noriaki .
TUMOR BIOLOGY, 2011, 32 (05) :1031-1047